Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples